Mar 10
Hopes dashed as Alzheimer’s drug fails clinical trial
NY Times It seemed somewhat unlikely, but in recent years an old Russian hay fever pill had become one of the world’s best hopes for treating the growing epidemic of Alzheimer’s disease.
|
|
Huperzine A for Alzheimer’s disease.(Alternative Medicine: AN EVIDENCE-BASED APPROACH): An article from: Family Practice News $9.95 This digital document is an article from Family Practice News, published by Thomson Gale on September 15, 2006. The length of the article is 959 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Hupe… |
|
|
Donepezil may cut death risk in severe AD by 50%.(Geriatric Psychiatry)(treating Alzheimer’s disease ): An article from: Clinical Psychiatry News $9.95 This digital document is an article from Clinical Psychiatry News, published by Thomson Gale on October 1, 2006. The length of the article is 444 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Don… |
|
|
Donepezil makes difference in severe Alzheimer’s.(reports of clinical trials): An article from: Clinical Psychiatry News $5.95 This digital document is an article from Clinical Psychiatry News, published by Thomson Gale on July 1, 2006. The length of the article is 633 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Donepe… |
Mail this post
Recent Comments